Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Secretion of prednisolone into breast milk.

Literature DB >> 1211963

Secretion of prednisolone into breast milk.

Abstract

The secretion of 3H in the breast milk of seven volunteers was studied over a period of about 48 hours after the oral administration of 5 mg of 3H-prednisolone. A range of 0.07 to 0.23% of the dose per litre was recovered.

Entities: Chemical

Mesh：

Substances：
Prednisolone

Year: 1975 PMID： 1211963 PMCID： PMC1545728 DOI： 10.1136/adc.50.11.894

Source DB: PubMed Journal: Arch Dis Child ISSN： 0003-9888 Impact factor: 3.791

8 in total

1. PROLONGED NEONATAL UNCONJUGATED HYPERBILIRUBINEMIA ASSOCIATED WITH BREAST FEEDING AND A STEROID, PREGNANE-3(ALPHA), 20(BETA)-DIOL, IN MATERNAL MILK THAT INHIBITS GLUCURONIDE FORMATION IN VITRO.

Authors: I M ARIAS; L M GARTNER; S SEIFTER; M FURMAN
Journal: J Clin Invest Date: 1964-11 Impact factor: 14.808

Review 2. EXCRETION OF DRUGS IN MILK--A REVIEW.

Authors: J A KNOWLES
Journal: J Pediatr Date: 1965-06 Impact factor: 4.406

3. ORAL-CONTRACEPTIVE FEMINIZATION OF A NORMAL MALE INFANT: REPORT OF A CASE.

Authors: E M CURTIS
Journal: Obstet Gynecol Date: 1964-02 Impact factor: 7.661

4. [Post-natal growth disorders in rats after administration of cortisone to the mother in pregnancy or lactation].

Authors: L MERCIER-PAROT
Journal: C R Hebd Seances Acad Sci Date: 1955-06-06

Review 5. Drugs and breast milk.

Authors: C S Catz; G P Giacoia
Journal: Pediatr Clin North Am Date: 1972-02 Impact factor: 3.278

6. Radioactivity in the breast milk of lactating women after oral administration of 3H-norethynodrel.

Authors: K R Laumas; P K Malkani; S Bhatnagar; V Laumas
Journal: Am J Obstet Gynecol Date: 1967-06-01 Impact factor: 8.661

7. Breast milk jaundice. Effect of inhibitory breast milk and 3 alpha, 20 abeta-pregnanediol on glucuronyl transferase.

Authors: T Hargreaves; R F Piper
Journal: Arch Dis Child Date: 1971-04 Impact factor: 3.791

8. Radioactivity in the milk of subjects receiving radioactive 19-norsteroids.

Authors: G Pincus; G Bialy; D S Layne; M Paniagua; K I Williams
Journal: Nature Date: 1966-11-26 Impact factor: 49.962

8 in total

12 in total

Review 10. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors: J B Besunder; M D Reed; J L Blumer
Journal: Clin Pharmacokinet Date: 1988-04 Impact factor: 6.447

Secretion of prednisolone into breast milk.

1. PROLONGED NEONATAL UNCONJUGATED HYPERBILIRUBINEMIA ASSOCIATED WITH BREAST FEEDING AND A STEROID, PREGNANE-3(ALPHA), 20(BETA)-DIOL, IN MATERNAL MILK THAT INHIBITS GLUCURONIDE FORMATION IN VITRO.

Review 2. EXCRETION OF DRUGS IN MILK--A REVIEW.

3. ORAL-CONTRACEPTIVE FEMINIZATION OF A NORMAL MALE INFANT: REPORT OF A CASE.

4. [Post-natal growth disorders in rats after administration of cortisone to the mother in pregnancy or lactation].

Review 5. Drugs and breast milk.

6. Radioactivity in the breast milk of lactating women after oral administration of 3H-norethynodrel.

7. Breast milk jaundice. Effect of inhibitory breast milk and 3 alpha, 20 abeta-pregnanediol on glucuronyl transferase.

8. Radioactivity in the milk of subjects receiving radioactive 19-norsteroids.

1. Treatment of rheumatic diseases.

2. Optimum management of asthma in pregnancy.

3. Treatment of asthma.

Review 4. Inflammatory bowel disease in pregnancy: a review.

Review 5. Immune thrombocytopenia and pregnancy.

Review 6. Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences.

7. Ankylosing spondylitis. Current drug treatment.

Review 8. Multiple sclerosis and pregnancy: therapeutic considerations.

Review 9. Drugs in human milk. Clinical pharmacokinetic considerations.

Review 10. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).